What is 'community resilience'? Responding to COVID-19 in rural Zimbabwe.


Journal

BMJ global health
ISSN: 2059-7908
Titre abrégé: BMJ Glob Health
Pays: England
ID NLM: 101685275

Informations de publication

Date de publication:
09 2022
Historique:
received: 10 05 2022
accepted: 28 07 2022
entrez: 27 9 2022
pubmed: 28 9 2022
medline: 30 9 2022
Statut: ppublish

Résumé

Based on real-time recording and reflection of responses to the COVID-19 pandemic, this article identifies the features of 'community resilience' across sites in rural Zimbabwe. The findings confirm the importance of local knowledge, social networks and communication, as highlighted in the literature. In addition, a number of other aspects are emphasised, including the importance of adaptable livelihoods, innovation and collective learning. Flexible adaptation was especially important for responding to lockdowns, as livelihoods had to be reconfigured in response to public health measures. Meanwhile, innovation and shared learning was vital for generating local treatment responses to the disease. In the Zimbabwe context, these adaptation and innovation capabilities emerge from a particular historical experience where resilience in the face of harsh economic conditions and in the absence of state support has been generated over years. This is often a more resigned coping than a positive, empowering, transformational form of resilience. While adaptation, innovation and shared learning capabilities proved useful during the pandemic, they are not evenly spread, and there is no singular 'community' around which resilience emerges. The article therefore argues against seeing 'community resilience' as the magic bullet for disaster preparedness and response in the context of pandemics. Instead, the highly differentiated local practices of adaptation, innovation and shared learning-across gender, age and wealth differences-should be seen as an important complement to public, state-led support in health emergencies and so are part of a wider, plural health system.

Identifiants

pubmed: 36167406
pii: bmjgh-2022-009528
doi: 10.1136/bmjgh-2022-009528
pmc: PMC9515458
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Am J Trop Med Hyg. 2020 Aug;103(2):564-569
pubmed: 32484156
Pan Afr Med J. 2020 Aug 11;35(Suppl 2):143
pubmed: 33193958
Ambio. 2021 Oct;50(10):1774-1777
pubmed: 33721222
PLoS Curr. 2017 Feb 01;9:
pubmed: 29188132
Am J Community Psychol. 2008 Mar;41(1-2):127-50
pubmed: 18157631
BMJ Glob Health. 2021 Apr;6(4):
pubmed: 33820807
Lancet Diabetes Endocrinol. 2020 Aug;8(8):664-665
pubmed: 32707106
PLoS One. 2020 Jun 24;15(6):e0235108
pubmed: 32579602
Front Res Metr Anal. 2021 Jan 15;5:602200
pubmed: 34553122
Curr Environ Health Rep. 2019 Sep;6(3):167-173
pubmed: 31267349
Perspect Public Health. 2020 Nov;140(6):305-308
pubmed: 32820710
BMJ Nutr Prev Health. 2020 Sep 12;3(2):205-212
pubmed: 33521530
BMJ Glob Health. 2020 May;5(5):
pubmed: 32424013
Health Place. 2012 Mar;18(2):286-95
pubmed: 22037322
Bull World Health Organ. 2021 Feb 01;99(2):85-91
pubmed: 33551502
Lancet Infect Dis. 2020 Aug;20(8):875
pubmed: 32687807
BMJ Glob Health. 2021 Mar;6(3):
pubmed: 33692145
Health Res Policy Syst. 2020 Jul 17;18(1):81
pubmed: 32680527

Auteurs

Iyleen Judy Bwerinofa (IJ)

Hippo Valley, Chiredzi, Zimbabwe.

Jacob Mahenehene (J)

Chikombedzi, Chiredzi, Zimbabwe.

Makiwa Manaka (M)

Chatsworth, Gutu, Zimbabwe.

Bulisiwe Mulotshwa (B)

Matobo, Bulawayo, Zimbabwe.

Felix Murimbarimba (F)

Victoria Ranch, Masvingo, Zimbabwe.

Moses Mutoko (M)

Wondedzo, Masvingo, Zimbabwe.

Vincent Sarayi (V)

Mvurwi, Mazowe, Zimbabwe.

Ian Scoones (I)

Institute of Development Studies, University of Sussex, Falmer, UK i.scoones@ids.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH